Nova Mentis Life Science (NOVA.C) announced it has filed for orphan drug designation with the European Medicines Agency (EMA) for its propriety psilocybin drug to help treat patients with fragile…
Autism Data Bank
Nova Mentis Life Science (NOVA.C) announced they have received Canadian approval for their North American autism clinical study. They received Institutional Review Board (IRB) approval in Canada on its…
When you write about the psychedelics industry, most of the people you speak with are corporate executives and most of what you read comes from PR personnel, so speaking…